David is a Senior Immunologist within the Translational Science team at Epitopea. He brings a wealth of experience in immunotherapy product development through roles at GammaDelta Therapeutics, Takeda and Bastion Therapeutics.

He is passionate about translating research into the clinic and bringing novel therapies to patients in need. David holds a PhD from Queen Mary University of London where he studied Haemato-oncology at Barts Cancer Institute.